← Back
$KROS All transactions

Keros Therapeutics, Inc.

A

$ Value

$0

Shares

60,000

Price

$0

Filed

Feb 26

Insider

Name

Regnante Keith

Title

CHIEF FINANCIAL OFFICER

CIK

0001682068

Roles

Officer

Transaction Details

Transaction Date

2026-02-24

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

60,000

Footnotes

One-fourth (1/4th) of the shares subject to the option shall vest on February 24, 2027, and the remaining shares subject to the option shall vest in twelve substantially equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Filing Info

Accession No.

0001682068-26-000005

Form Type

4

Issuer CIK

0001664710

Regnante Keith's History

Date Ticker Type Value
2026-02-24 KROS A $0
2026-02-18 KROS $77K

Other Insiders at KROS (90d)

Insider Bought Sold Last
BIENAIME JEAN JACQUES $34K 2026-04-15
Regnante Keith
CHIEF FINANCIAL OFFICER
$77K 2026-02-18
Seehra Jasbir
CHIEF EXECUTIVE OFFICER
$113K 2026-04-02
Newton Charles W. 2026-03-09
Lerner Lorena Raquel
Chief Science Officer
$63K 2026-02-18
Lerner Lorena Raquel
Chief Scientific Officer
2026-02-24
Cho Esther
Chief Legal Officer
2026-02-24
Cho Esther
SVP, General Counsel
$78K 2026-02-18